Futura Medical Share Discussion Threads

[mikethebike4] 10/11/2022 15:50

LBO

Just a reminder for sensible people :-

Our main competitor - the little blue pill - has these problems

We all know what comes with Viagra don't we ?

Viagra side effects

Viagra may cause some unwanted side effects.

Side effects may include:

sensitivity to light
muscle aches
heartburn
nose bleeding
flushed skin
problems falling asleep
tingling in the arms, feet, legs, or hands
numbness in the arms, feet, legs, or hands
headache
diarrhea
heartburn
trouble differentiating between colors like blue and green
seeing a blue tinge on things

Viagra may also cause serious side effects that require immediate medical attention. Symptoms may include:

chest pain
fainting
blurred vision
severe, sudden loss of vision
ringing in ears
sudden loss of or decrease in hearing
dizziness
rash
burning during urination
itching during urination
shortness of breath that worsens
an erection that lasts longer than 4 hours and may be painful

Who would risk it - obviously Mr LBO does - he's dead keen

[lbo] 10/11/2022 13:58

So is Joe! LOLJoeStalin - 30 Sep 2019 - 10:07:37 - 5937 of 10774FUTURA a winner for 2015 - says it all!JoeStalin - 18 Jul 2018 - 09:00:46 - 4354 of 10775'jam tomorrow' is a very easy promise to make.JoeStalin - 22 Jun 2018 - 14:12:24 - 4288 of 10775What's another year after all?At FUM, time is measured in decades.JoeStalin - 25 Apr 2018 - 16:07:34 - 4147 of 10775There seems to be an unlimited number of ways of saying "Jam tomorrow".JoeStalin - 21 Mar 2018 - 13:50:44 - 3985 of 10775A lifestyle company, but not for the shareholders.

[lbo] 10/11/2022 13:57

Mike is just desperately trying to get the naive to buy in so he can try reduce his losses at their expense. He has even in the past accused the company CEO of basically telling lies! And now he is claiming the FTC, the ASA and the court rulings are all telling lies!Seems everyone tells lies except Mike!? LOLmikethebike4 - 11 Apr 2018 - 14:35:10 - 4072 of 11141Having had similar waffling, 'smoke-screen' answers from Mr Barder over the years which have turned out to end in exactly nothing I am loathe to give any credence to virtually everything he saysmikethebike4 - 11 Apr 2018 - 15:58:28 - 4091 of 11141Company is massively over valued if you go by 'concrete' results !mikethebike4 - 11 Apr 2018 - 15:14:56 - 4082 of 11141I only try and bring some sort of balance into the equation to help the gullible not get carried away with fanciful future projections.I would like nothing better than to be proved wrong about Mr Barder (our CEO since 2001) and to sale away into the sunset grasping 5 times as many £s in my fist as I paid for the sharesUnfortunately for people like J7J, Mr Barder has been through this advisors process before - with CSD500 - and look where we've got in 17 years - sales of the product did not even equal the money we paid him to be our CEO for 2017 !mikethebike4 - 06 Dec 2017 - 10:32:27 - 3468 of 10591"A couple of decent deals and will be back off to the races."Do you have any idea of how long shareholders have been using these wordsmikethebike4 - 23 Mar 2017 - 09:52:33 - 2560 of 10591As someone who has been invested for many years and who attended an AGM years ago and complained to Barder about the very slow progress, I am very frustrated.All the time the Board are drawing good salaries off the backs of shareholders money they have very little incentive to get off their backsides and get 'selling' - thats what running a company is all about at the end of the day!mikethebike4 - 24 Feb 2020 - 09:11:58 - 7290 of 9713why should it be any different this time when you've still got the same useless lot running the showmikethebike4 - 07 Jan 2019 - 11:22:52 - 4692 of 9641I repeat I very much hope you are right - no one would be happier than me if you are - however I stupidly (in hindsight) bought in when everything looked really rosy - we were told there were loads of 'distributors' all 'champing at the bit to get selling a wonderful industry disruptive product (which it still is incidentally) once the 2 year shelf-life problem was fixed. This was despite the fact that the Holland/Belgium distributor was quite happy and successful selling them with the original 18 months shelf-lifeAnd where are we now years later - one tiny distributor from which Futura receives a total sales income only just about covering Mr Barders employment remunerationI just hope this MED/TPR situation is not just a repeat of CSD. As to why I don't just sell up, well my shareholding is worth such a tiny proportion of what I paid for it I might just as well hang on in the hope that new shareholders getting in now are luckier than I was and I can get some of my money back - I think what we need is Mr Barders retirement - that should give the share price a kick

[mikethebike4] 10/11/2022 13:52

LBO

Great that you've come up with the infinitely repeated goods so soon - I thought you were asleep or perhaps even rubbing some more truth lubricant into the most gullible portion of your biosphere

One day this obsession of yours will all be behind you and you will be nearly normal again

[lbo] 10/11/2022 10:28

The FTC is a more reliable source then the rampers and has jurisdiction over lower class medical devices like Med3000



In terms of advertising and promotion, for most over-the-counter medical devices, the FDA and FTC exercise joint regulatory authority over product labelling and advertising. The FDA has primary jurisdiction over labelling for all medical devices and advertising for restricted devices (typically Class III), while FTC has primary jurisdiction over advertising of ˜unrestricted’ medical devices (Class I and most Class II devices). The FDCA prohibits the distribution or receipt in interstate commerce of a misbranded medical device, which includes a device bearing false or misleading labelling. Claims in device labelling, including product websites, that are outside the scope of the device cleared uses can misbrand, and even adulterate the device, another prohibited act under the FDCA




Remember, the anonymity of the Internet should make you skeptical of what anyone says if you don’t know who they are. Before making a buy or sell decision on a stock, make sure you are dealing with a reliable source. And if that source is an anonymous stock forum poster, that source is rarely reliable.

[mikethebike4] 10/11/2022 09:03

COME ON LBO

It's at least 20 hours since you repeated yourself !!

You can do better than this

[j777j] 10/11/2022 08:30

The fact lbo spend his entire life on one share just shows how worried the competition must be.


A 5% market share of a $5 billion market would bring in annual revenues well above the current market cap


That means the share could go to 400p plus in the next couple of years


Eroxon has been manufactured and is due to be launched in the next months.


Separattley in the USA,the FDA approval could be done and dusted by Q2 next year

[lbo] 09/11/2022 13:28

And if you believe that and the story that just an alcohol and water gel that cools by evaporation is the holy grail answer to ED. Then Reckitt will also be launching their own placebo arousal gel too! ROFLMAO

‘When A Claimed Trade Secret Isn't In Fact A Secret’






We are not going to progress on this particular compound for normal commercial reasons which we do not wish to go into, GSK said



The cooling effect of a topically applied product can be evaluated using a validated handheld thermal imaging system. When the gel matrix is destroyed after application to the skin, the bound water and alcohol evaporates and a measurable cooling-effect results.

Voltaren vehicle gel application resulted in a rapid reduction of skin surface temperature by 5.1°C after only 3 min



There is a risk that some claims will either be challenged in future (eg on the grounds of non-obviousness or existence of prior art) and/or that another technology may be employed to achieve a similar effect. The protracted development times mean the clock has been ticking on the original issued patents, reducing the protected commercial product

[j777j] 09/11/2022 13:21

Not long now folks


Rollout across EU and UK all tooled up


FDA clearance should be fairly swift within the next few months

[lbo] 09/11/2022 12:37

LOL

No they published only ad hoc and pooled results from a small (less then one hundred participants) deficient unblinded and uncontrolled medical device study. The study they say ‘included men who had organic and psychological ED, or a combination of both’. Why haven’t they given then the efficacy data in each subgroup over time? None of what they have said still does not substantiate any effects beyond a placebo according to the FTC rulings.



What happened next gets to the FTCs allegation that the respondents, in effect, deceptively sliced and diced the data in search of a positive marketing message. According to the complaint, the respondents subjected the data to post hoc analyses of different subgroups of test subjects. (The complaint describes a post hoc analysis as statistical analysis conducted after the data have been collected in hopes of discovering statistical relationships that suggest cause and effect.) The FTC concern is that unplanned, post hoc subgroup analyses pose a high risk of generating spurious findings.



This placebo effect was most pronounced in men with post-traumatic stress disorder (PTSD), suggesting that for some men psychology is more important than physiology in dealing with erectile dysfunction, said lead researcher Alexander Stridh of the Karolinska Institute's department of clinical neuroscience, in Stockholm.
"The placebo response seems largely more important when the cause of [erectile dysfunction] is mainly due to psychogenic factors, as in post-traumatic stress disorder," Stridh said.
For this analysis, his team pooled data from 63 studies involving more than 12,500 men.
The studies showed that Viagra and its relatives had a strong effect helping men who had erectile dysfunction due to chronic illness.
"The studies included in this meta-analysis mainly were trials on men with [erectile dysfunction] due to cardiovascular disease, diabetes, etc.," Stridh said. "It is likely that there is a limit to how much the brain can influence erectile function when the problem is mainly dysfunctions in blood vessels or peripheral nerves."
But the researchers found that men in the placebo arm of these trials also experienced a small to moderate improvement of their erectile function. The placebo effect was notably stronger among men with PTSD.
"This paper highlights the importance of taking into account the underlying cause of [erectile dysfunction] in each individual, which could also help determine what the best treatment option would be," Stridh said. Some men might benefit more from psychotherapy, others with a pharmaceutical approach, he added.

[petroc] 09/11/2022 11:29

They published enough data to show that you were completely wrong, LiarBO. Chucking three massive steaming piles of copy/pasted repetitions won't hide it.

[lbo] 09/11/2022 11:04

Yet another feeble attempt at deflection by Petroc the proven liar. Fm71 was a unblinded and uncontrolled study. The full study design and all the full results have never been fully published or fully peer reviewed. The only information and data anyone has seen is an RNS press release which gave some 'pooled' data but not all of it. Futura by their own admission has admitted it is exploiting the ‘least burdensome’ route of the De novo medical device pathway



Devices are subject to weaker standards than drugs because they are regulated under a different law. The Medical Device Amendments of 1976 was intended to encourage innovation while allowing for a range of review standards based on risk, according to legal expert Richard A. Merrill. An array of corporate lobbying has since prompted Congress to ease regulations and make it easier for devices to get the FDA OK

Journalists need to scrutinize the claims.
Journalists have a responsibility to report this lack of evidence, but they often dont. Investigative journalist Jeanne Lenzer, who wrote a book about the under-regulated medical device industry, says more dogged reporting is needed: We really dont know what we are getting with many of these devices

Ninety-nine percent of devices never have to provide clinical data, thanks in part to the 2002 Medical Devices User Fee Act, which requires the FDA to use the least burdensome route

For the few devices subject to a scientific review, the quality standards are flimsy. Randomized controlled trials, the gold standard, are infrequent. Most studies are unblinded, and thus prone to bias. The FDA settles for loosely defined reasonable assurance that a device is safe and effective, versus its higher standard of substantial evidence for drugs, which require studies with comparison groups that didnt receive the same treatment. Thus, data that would never be sufficient to support the approval of a drug can result in the approval of a device used to treat the same condition, potentially diverting patients from effective drugs to less-effective devices.



When Futura describe the efficacy of MED3000, they are talking about improvement seen over the course of the treatment period known as 'change vs. baseline'.

Large improvements vs. baseline are common in the placebo groups in clinical trials of a wide range of conditions. This improvement is sometimes attributed to the 'placebo effect'

[lbo] 09/11/2022 10:55

The rates of Viagra use are increasing in young men because they are young and take even higher risks with alcohol etc!



They want something they believe is effective and discreet. Even in FM71 which was unblinded and inadequately controlled it was still proven that a low dose of Tadalafil was STILL MORE EFFECTIVE THEN MED3000! The same reason why some even take twice the recommended dose! These young men dont want a messy indiscreet placebo gel that they then have to explain their need for a placebo gel or their ‘performance anxiety’ to their one night stand or new partner! LOL

[lbo] 09/11/2022 10:50

Even placebos like Med3000 can cause side effects!

In FM71 alone. 4.3% of MED3000 users had headaches and 4.3% of MED3000 users also noted nausea.

And an instance of mild local burning was noted in MED3000 users too. Ouch!



A Viagra study also showed using a placebo was also just as likely to harm you. It compared some 4,500 patients taking the drug to about 3,100 on placebo. So based on that study Med3000 even as a placebo is just as likely to harm you as viagra.



A new review of data from 250,726 trial participants has found that 1 in 20 people who took placebos in trials dropped out because of serious adverse events (side effects). Almost half of the participants reported less serious adverse events. The adverse events ranged from abdominal pain and anorexia to burning, chest pain, fatigue, and even death.